• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常蛋白质饮食与L-鸟氨酸-L-天冬氨酸治疗肝性脑病

Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.

作者信息

Ndraha Suzanna, Simadibrata Marcellus

机构信息

Department of Internal Medicine, Faculty of Medicine, University of Indonesia - Dr. Cipto Mangunkusumo Hospital, Jl. Diponegoro no. 71, Jakarta Pusat 10430, Indonesia.

出版信息

Acta Med Indones. 2010 Jul;42(3):158-61.

PMID:20724770
Abstract

Excessive protein intake can cause hepatic encephalopathy (HE). Restricting protein in HE is becoming a controversy, because it can worsen malnutrition. This article reports the case of an under nourishment HE which is treated with L-ornithine-L-aspartate (LOLA) and given appropriate diet according to the nutrition status. A 62-year-old man came with chief complaint of having reduced consciousness since 6 hours before admission. He had been diagnosed as liver cirrhosis for 6 years. Several days prior to admission he took high protein diet. Physical examination revealed under nutrition and unconsciousness. Hepatic encephalopathy was confirmed with low critical flicker test (CFF), and high blood ammonia level. He was treated with adequate diet and LOLA to decrease blood ammonia and improve the CFF. During the treatment, consciousness improved to normal, CFF increased and ammonia level decreased. In this case, the HE was treated with LOLA without protein restriction. The HE improvement, in this circumstance may be caused of LOLA treatment that helps decrease the plasma ammonia level. Adequate diet, 35-40 kcal/kgBW/d and protein intake 1.5 g/kgBW/d, has been administered safely to this patient with stage II hepatic encephalopathy. LOLA seemed to be effectively reduced ammonia level and improved the encephalopathy.

摘要

蛋白质摄入过多可导致肝性脑病(HE)。在肝性脑病中限制蛋白质摄入正引发争议,因为这可能会加重营养不良。本文报告了一例营养不良性肝性脑病的病例,该病例采用L-鸟氨酸-L-天冬氨酸(LOLA)治疗,并根据营养状况给予适当饮食。一名62岁男性因入院前6小时意识减退为主诉前来就诊。他被诊断为肝硬化6年。入院前几天他摄入了高蛋白饮食。体格检查显示营养不良和昏迷。通过低临界闪烁频率试验(CFF)和高血氨水平确诊为肝性脑病。给予他适当饮食和LOLA以降低血氨水平并改善CFF。治疗期间,意识恢复正常,CFF升高,血氨水平降低。在该病例中,肝性脑病采用LOLA治疗且未限制蛋白质摄入。在这种情况下,肝性脑病的改善可能是由于LOLA治疗有助于降低血浆氨水平。已安全地给予该II期肝性脑病患者充足的饮食,即35 - 40千卡/千克体重/天,蛋白质摄入量为1.5克/千克体重/天。LOLA似乎能有效降低氨水平并改善脑病。

相似文献

1
Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.正常蛋白质饮食与L-鸟氨酸-L-天冬氨酸治疗肝性脑病
Acta Med Indones. 2010 Jul;42(3):158-61.
2
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.一项关于静脉注射 L-鸟氨酸-L-天冬氨酸对肝硬化患者姿势控制影响的双盲、随机、安慰剂对照试验。
Liver Int. 2010 Apr;30(4):574-82. doi: 10.1111/j.1478-3231.2010.02213.x.
3
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].磁共振波谱法(¹H-MRS)检测L-鸟氨酸-L-天冬氨酸药物治疗后亚临床和显性肝性脑病及治疗控制情况
Z Gastroenterol. 2005 Apr;43(4):373-8. doi: 10.1055/s-2004-813917.
4
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.L-鸟氨酸-L-天冬氨酸输注对肝硬化和肝性脑病患者的治疗效果:一项安慰剂对照双盲研究的结果
Hepatology. 1997 Jun;25(6):1351-60. doi: 10.1002/hep.510250609.
5
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.L-鸟氨酸-L-天冬氨酸作为辅助治疗对肝硬化肝性脑病患者的疗效。
J Coll Physicians Surg Pak. 2011 Nov;21(11):666-71.
6
Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.采用改良的高热量高蛋白饮食改善肝性脑病。
Rom J Gastroenterol. 2005 Sep;14(3):231-8.
7
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.L-鸟氨酸L-天冬氨酸和支链氨基酸对伴有营养不良的肝硬化患者脑病及营养状况的影响
Acta Med Indones. 2011 Jan;43(1):18-22.
8
L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.L-鸟氨酸-L-天冬氨酸输注治疗肝性脑病的疗效
J Coll Physicians Surg Pak. 2008 Nov;18(11):684-7.
9
l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.门冬氨酸鸟氨酸治疗肝硬化肝性脑病的系统评价:随机对照试验的荟萃分析。
J Gastroenterol Hepatol. 2013 May;28(5):783-92. doi: 10.1111/jgh.12142.
10
Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.肝硬变患者肝性脑病的二级预防:L-鸟氨酸-L-天冬氨酸与安慰剂的双盲随机对照试验
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):951-958. doi: 10.1097/MEG.0000000000001137.